ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

HLVX HilleVax Inc

14.53
0.04 (0.28%)
Fuera de horario
Última actualización: 15:06:59
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
HilleVax Inc HLVX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.04 0.28% 14.53 15:06:59
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
14.49 13.55 14.61 14.53 14.49
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
09/5/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
09/5/202415:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202415:10EDGAR2Form 8-K - Current report
09/5/202415:05GLOBEHilleVax Reports First Quarter 2024 Financial Results and..
20/3/202415:00GLOBEHilleVax Reports Full Year 2023 Financial Results and..
12/2/202418:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202415:05GLOBEHilleVax to Present at Guggenheim 6th Annual Biotechnology..
02/2/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202416:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/1/202406:49DJNHilleVax Taps Sean McLoughlin as Chief Operating Officer
18/1/202406:05EDGAR2Form 8-K - Current report
18/1/202406:00GLOBEHilleVax Announces Executive Management Appointment of Sean..
08/1/202406:05EDGAR2Form 8-K - Current report
08/1/202406:00GLOBEHilleVax and Kangh Announce Exclusive License Agreement for..
03/1/202417:28GLOBEHilleVax to Present at the 42nd Annual J.P. Morgan..
18/12/202316:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202316:28EDGAR2Form 144 - Report of proposed sale of securities
08/12/202316:11EDGAR2Form 8-K - Current report
05/12/202315:56EDGAR2Form 144 - Report of proposed sale of securities
05/12/202315:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202320:14EDGAR2Form 144 - Report of proposed sale of securities
20/11/202315:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202316:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202315:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:10EDGAR2Form 8-K - Current report
09/11/202315:05GLOBEHilleVax Reports Third Quarter 2023 Financial Results and..
01/11/202315:48GLOBEHilleVax to Present at Upcoming Investor Conferences
26/9/202315:01GLOBEHilleVax to Participate in Fireside Chat at the 2023 Cantor..
25/9/202306:00GLOBEHilleVax Announces Closing of Public Offering of Common..
20/9/202315:03EDGAR2Form 8-K - Current report
20/9/202315:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/9/202319:05GLOBEHilleVax Announces Pricing of Public Offering of Common..
19/9/202315:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/9/202315:09GLOBEHilleVax Announces Proposed Public Offering of Common Stock
14/8/202306:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202306:05EDGAR2Form 8-K - Current report
14/8/202306:00GLOBEHilleVax Reports Second Quarter 2023 Financial Results and..